Wisconsin MPJE Practice Questions

A pharmacist may not administer a vaccine unless he or she has successfully completed 12 hours in a course of study and training approved by ACPE or the Board, including training in vaccination storage, protocols, administration technique, emergency procedures, and record keeping.

Every pharmacy must be under the control of the managing pharmacist who signed the pharmacy license application, the most recent renewal application, or the most recent amended schedule of operations. The managing pharmacist is responsible for the professional operations of the pharmacy.

A pharmacist cannot manage more than one community and one institutional pharmacy at a time, and must be engaged in the practice of pharmacy at each location they supervise.

Within 24 hours after an occurrence of any of the following, a pharmacist or pharmacy shall report the occurrence electronically, by facsimile, by telephone, or in writing to a local health department/department of health services:

• An unusual increase in the number of nonprescription drugs or prescriptions dispensed for the treatment of medical conditions specified by the department of health services

• An unusual increase in the number of prescriptions dispensed that are antibiotic drugs

• The dispensing of a prescription drug for treatment of a disease that is relatively uncommon or may be associated with bioterrorism.

When submitting a report, the pharmacist or pharmacy shall include personally identifying information other than a social security number concerning an individual who is dispensed a prescription or who purchases a nonprescription drug product of concern.

When transferring a non-controlled substance, the prescription record must include the following information (which may be written on the invalidated prescription order or recorded in the computer system):

• The word “VOID” written on the face of the invalidated prescription order or recorded in a similar manner in a computer system

• The name and address of the pharmacy to which it is transferred

• The date of transfer

• The first and last name of the pharmacist transferring the prescription.

Prescriptions shall be stored in a secure delivery system immediately upon delivery to the location of the delivery system. Only the patient or patient’s agent shall be able to open the door or locker containing only the patient’s prescription.

The delivery system must be designed in a way which does not disclose protected health information. It must also maintain appropriate environmental controls, including temperature and humidity, to prevent drug adulteration. Using the delivery system does not exempt the requirement of an identification card for certain controlled substances.

A log must be maintained by the dispensing pharmacy of all prescriptions delivered to the delivery system. The delivery system must be inventoried at least weekly and a list of unclaimed prescriptions must be reviewed by the pharmacist.

No identification card is required for a Schedule II or III prescription if:

• The drug is being administered or dispensed directly to the ultimate user by the prescriber

• If the pharmacist, pharmacy technician, or other person dispensing/delivering the drug has personal knowledge of the person whom the drug is dispensed or delivered to and that the person is the ultimate user or the ultimate user’s authorized representative

• The drug is delivered to a healthcare facility to be administered in the facility

Additionally, there is an exemption to the identification card requirement when the drug is lawfully delivered to the patient’s home, or any other address requested by the patient, through mail, common carrier, or delivery service. A signature is required upon delivery.

No person other than a physician, dentist, veterinarian, or pharmacist may purchase more than 7.5 grams of pseudoephedrine contained in a pseudoephedrine product within a 30-day period without the authorization of a physician, dentist, or veterinarian.

The transfer of original prescription information for a controlled substance listed in Schedules III–IV is permitted, but not for a Schedule II substance under federal law. Schedule II controlled substances may not be transferred.

MS Contin is a Schedule II controlled substance.

No prescription containing a controlled substance listed in Schedule III or IV may be dispensed or renewed more than 6 months after the date on which it was issued and no prescription is authorized to be renewed more than 5 times.

No pharmaceutical service may be provided to any person unless a pharmacist is present in the pharmacy to provide or supervise the service, except in the following locations:

• A healthcare facility

• The office or clinic of a practitioner

• A county jail, rehabilitation facility, state prison, or county house of correction.

A facility may have one or more emergency medication kits. All emergency medication kits shall be under the control of a pharmacist. The emergency kit shall be sealed and stored in a locked area. A pharmacist shall be responsible for proper control and accountability for such emergency kits within the LTCF.

This includes the requirements that the LTCF and the providing DEA-registered hospital, pharmacy, or practitioner maintain complete and accurate records of the controlled substances placed in the emergency kits, maintain complete and accurate records regarding the disposition of those substances, and take at least monthly physical inventories.

A pharmacist may not extend a prescription order for a drug that is a controlled substance.

A person who has successfully completed his or her second year in, and is enrolled at, an accredited school of pharmacy, may practice pharmacy. However, they are limited to performing these duties under the direct supervision of a person licensed as a pharmacist by the Board. They may administer vaccines or drugs as authorized under Wisconsin statutes.

A pharmacist may, upon the prescription order of a practitioner providing expedited partner therapy, dispense an antimicrobial drug as a course of therapy for the treatment of chlamydial infections, gonorrhea, or trichomoniasis to the practitioner’s patient or a person with whom the patient has had sexual contact for use by the person with whom the patient has had sexual contact.

The pharmacist shall provide consultation and shall ask whether the person for whom the antimicrobial drug has been prescribed is allergic to the antimicrobial drug and advise that person to discontinue the use of the antimicrobial drug if the person is allergic to or develops signs of an allergic reaction to the antimicrobial drug.

A pharmacist is immune from civil liability for injury to or the death of a person who takes an antimicrobial drug dispensed for that person under these regulations in connection with expedited partner therapy if the antimicrobial drug is dispensed.

A person authorized to administer a vaccine may administer by injection epinephrine and diphenhydramine to a person experiencing an adverse reaction to a vaccine.

A prescription for a Schedule III or IV controlled substance may not be dispensed more than 60 days after the date of issue on the prescription order.